Mazama Capital Management’s Celgene Corp CELG Stock Holding History

Mazama Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-70,890	Closed	-$8.49M	–	264
2015 Q4	$8.49M	Buy	70,890 +15,860	+29%	+$1.83M	1.56%	15
2015 Q3	$5.95M	Sell	55,030 -2,248	-4%	-$279K	1.23%	21
2015 Q2	$6.63M	Buy	57,278 +9,615	+20%	+$1.1M	1.33%	15
2015 Q1	$5.5M	Buy	47,663 +710	+2%	+$84.8K	1.13%	22
2014 Q4	$5.25M	Buy	46,953 +1,417	+3%	+$149K	1.21%	16
2014 Q3	$4.32M	Buy	45,536 +9,195	+25%	+$830K	1.1%	25
2014 Q2	$3.12M	Buy	36,341 +22,877	+170%	+$1.74M	0.83%	41
2014 Q1	$940K	Sell	13,464 -5,666	-30%	-$449K	0.85%	49
2013 Q4	$1.62M	Buy	19,130 +7,340	+62%	+$581K	0.8%	45
2013 Q3	$909K	Buy	+11,790	New	+$826K	0.5%	85

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Mazama Capital Management's CELG Position: Q1 2016 in Review

Mazama Capital Management sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 70,890 shares — an estimated $8.49M sold.

Mazama Capital Management first reported a position in CELG in Q3 2013 and held it in 10 quarters. The position peaked at $8.49M in Q4 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Mazama Capital Management reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
Mazama Capital Management sold 70,890 Celgene Corp shares in Q1 2016, an estimated $8.49M.
Mazama Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 10 quarters.
Mazama Capital Management's Celgene Corp position peaked at $8.49M in Q4 2015.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.